Cosmos Health Inc. (COSM)

From the record

Cosmos Health Inc.'s filings since 2017 show 40 warning events of 3 kinds: a notice about its exchange listing (8-K item 3.01, 9 times, the latest 2025-12-18); an auditor change (8-K item 4.01, 6 times, the latest 2024-05-28); a late-report notice (Form NT 10-K or NT 10-Q, 25 times, the latest 2026-08-14) (its current reports).

From the record

Cosmos Health Inc.'s 10 filed years say what it did: revenue went from $7 million in fiscal 2016 to $65 million in fiscal 2025, up 28.7% a year; it rose in 8 of 9 years; the deepest fall was 10% from fiscal 2021 to fiscal 2022; net income was positive in 1 of 10 of those years (its annual reports).

From the record

Return on equity: in the fiscal year ended 2025-12-31, Cosmos Health Inc. lost about 104 cents for every dollar of shareholders' money, and gross profitability: its products earned about 12 cents per dollar of everything the company owns. Leverage: it owed about 72 cents per dollar of assets, and net share issuance: its share count grew 58.2% over the year (the filed statements).

From the record

Cosmos Health Inc.'s standing among 10 graded names in its industry family: revenue of $65 million in fiscal 2025 ranks in the bottom 45% by size; a net margin of -29.3% ranks in the bottom 35%; revenue growth of 9% a year over the last 3 filed years ranks in the top 45% (its annual reports).

From the record

Cosmos Health Inc.'s leadership, from its insiders' filings and its current reports: the chief executive on the record is Siokas, Grigorios (Chief Executive Officer, as filed), filing under that title since 2016-08-12, 10.3 years (top 6% of its family); the 7 officers and directors filing in the last fifteen months have been on the record a median of 4.5 years (top 50%); 4 officer or director changes were reported on Form 8-K since 2023-11-13, against the 7 people in charge now (top 28%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

From the record

Cosmos Health Inc.'s room to grow, from the newest filed statements (fiscal 2025): cash of $716 thousand against debt of $4 million leaves -4.7% of its assets as net cash, bottom 45% of its family; cash from operations less capital spending is -13% of revenue (bottom 35%); a gross margin of 12.1% (top 35%); research spending of 0.8% of revenue (top 25%) (its annual report).

From the record

Cosmos Health Inc.'s growth drivers, from the filed years to fiscal 2025: revenue grew 9% a year over the last three filed years against 28.7% over all 10, slowing (bottom 19% of its family); the newest year grew 19.9% (top 19%); research spending grew 77.4% a year (top 12%); capital spending grew -9.1% a year (top 44%) (its annual reports). Cosmos Health Inc. reported 4 lines of business in fiscal 2025: Wholesale at $59 million (91%), Nutraceuticals and Pharmaceuticals at $4 million (7%), Pharmamanufacturing at $2 million (3%), and 1 more; 3 of 3 grew against the year before (its annual report).

From the record

Cosmos Health Inc.'s newest year against its own record: revenue of $65 million in fiscal 2025 came in 15.3% above the $57 million its prior three years' pace pointed to (top 7% of its family); net income of $19 million against a prior three-year average of $16 million (bottom 21%); a net margin of -29.3% against -30.6% before (top 21%) (its annual reports).